This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Ten-Year Follow-up Study

Elizabeth A. Abel, MD; Enrique Sendagorta, MD; Richard T. Hoppe, MD; Chung-Hong Hu, MD

Arch Dermatol. 1987;123(7):897-901.

Abstract
• Since our preliminary report of psoralen plus longwave ultraviolet A (PUVA) therapy in ten patients with erythroderma-type or plaque-type mycosis fungoides (MF), we have treated 38 patients with biopsy-proved MF. Approximately one third, mostly patients with erythroderma, received PUVA as primary therapy; the remainder had recurrent disease following electron beam irradiation or topical mechlorethamine (Mustargen) hydrochloride. Follow-up data are presented in 29 patients who completed an initial course of PUVA given two to three times weekly. A complete clinical response was observed in ten patients with plaque-type MF and seven with erythroderma without Sézary syndrome. The PUVA therapy was palliative for patients with advanced disease, in combination with other therapies. The mean observation period was approximately five years. Despite maintenance PUVA, most patients relapsed between ten and twenty months and were treated with another intensive course. Long-term maintenance therapy with PUVA was necessary to control the disease.

(Arch Dermatol 1987;123:897-901)

Author Affiliations
From the Departments of Dermatology (Drs Abel, Sendagorta, and Hu) and Therapeutic Radiology (Dr Hoppe), Stanford (Calif) University School of Medicine.

Footnotes
Accepted for publication Jan 20, 1987.

Reprints not available.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Topical Nitrogen Mustard in the Management of Mycosis Fungoides: Update of the Stanford Experience
Kim et al.
Arch Dermatol 2003;139:165-173.
ABSTRACT | FULL TEXT  

Psoralen Bath Plus UV-A Therapy: Possibilities and Limitations
Luftl et al.
Arch Dermatol 1997;133:1597-1603.
ABSTRACT  

Rational Therapy for Cutaneous T-Cell Lymphomas in the 1990s: Fact or Fancy?
Bunn
Arch Dermatol 1995;131:603-605.
ABSTRACT  

Cutaneous T cell lymphomas
Bunn
BMJ 1994;308:551-552.
FULL TEXT